Schroeder Thilo's Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Dec 9, 2024
- Accession no.
- 0001415889-24-028638
- Filed
- Dec 9, 2024
- Trade date
- Dec 5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $60.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | Common Stock | PPurchaseAcquired | +543,478 | $46.00 | +$24,999,988 | 2,096,612 | Indirect | |
| Dec 5, 2024 | Common Stock | PPurchaseAcquired | +760,869 | $46.00 | +$34,999,974 | 760,869 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.